Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE Open-Label: Aripiprazole IM Depot Maintenance
NCT00731549Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2008
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Dec 2008; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00731549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731549.